Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-25-056197
Filing Date
2025-06-20
Accepted
2025-06-20 16:15:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0246250-424b5_pasithea.htm 424B5 9681
2 GRAPHIC image_001.jpg GRAPHIC 7141
  Complete submission text file 0001213900-25-056197.txt   20668
Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271010 | Film No.: 251061536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)